Cronos Group And Ginkgo Bioworks Announce Achievement Milestone In Cultured Cannabinoids Partnership; Cronos Says Has ‘successfully achieved the productivity target for cannabigerolic acid’
Cronos Group, Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos Group"), an innovative global cannabinoid company, and Ginkgo Bioworks ("Ginkgo"), which is building the leading horizontal platform